🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Treatment Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles directly for source information, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors market the drug there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Worries

However, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.

Several professionals stated the popularity for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and customer regulations, risking penalties, legal action or prison.

Service Reaction and Material Elimination

Based on the social media company, the platform has removed violative content and banned associated hashtags and query recommendations. The company stated it was committed to maintaining the platform secure and investing in enhancing compliance measures.

Digital Trading Activities

Research also found groups with up to 9,000 participants marketing the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of users, filled with images of weight loss, glowing testimonials and step-by-step instructions for mixing or injecting at residence.

Within moments of entering one group, a seller posted WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and guaranteed shipping within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Product Information and Costs

Within these groups, posts display dark colored packages with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service said it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting materials they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But fake injections are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has previously encountered individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly significant health risks”.